Return to Statistics Toolbox

Pathway mapping for Study ST004022

(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Treatment:57E (20 microM) | Doxycycline (y/n):yes | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):0.1 | MeAIB concentration (mM):0.5 (3)
Treatment:57E (20 microM) | Doxycycline (y/n):yes | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):5 | MeAIB concentration (mM):0.5 (1)
Treatment:57E (40 microM) | Doxycycline (y/n):yes | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):0.1 | MeAIB concentration (mM):0.5 (3)
Treatment:L-Alanine (20 mM) | Doxycycline (y/n):yes | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):0.1 | MeAIB concentration (mM):0.5 (3)
Treatment:L-Alanine (20 mM) | Doxycycline (y/n):yes | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):5 | MeAIB concentration (mM):0.5 (1)
Treatment:vehicle | Doxycycline (y/n):no | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):0.1 | MeAIB concentration (mM):0.5 (4)
Treatment:vehicle | Doxycycline (y/n):no | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):5 | MeAIB concentration (mM):0.5 (1)
Treatment:vehicle | Doxycycline (y/n):yes | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):0.1 | MeAIB concentration (mM):0.5 (4)
Treatment:vehicle | Doxycycline (y/n):yes | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):5 | MeAIB concentration (mM):0.5 (1)
Limit by pathway class:
Analysis:Combine data for all analyses?:     

  logo